The Breast Friends Podcast cover art

The Breast Friends Podcast

The Breast Friends Podcast

By: Dr. Jason Mouabbi and Dr. Paolo Tarantino
Listen for free

Season's Savings | £0.99/mo for 3 months

£5.99/mo after 3 months - terms apply. Cancel monthly
The Breast Friends Podcast is where cutting-edge breast cancer science meets real conversation. Hosted by Dr. Jason Mouabbi and Dr. Paolo Tarantino, two oncologists and trusted colleagues, the podcast breaks down the latest data, clinical trials, and treatment advances—while tackling the hard questions that shape real-world cancer care. Smart, honest, and human—because better conversations lead to better care.Dr. Jason Mouabbi and Dr. Paolo Tarantino Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • The Breast Friends Podcast Ep. 9 | Humanizing Cancer Care with Prof. Gabriella Pravettoni
    Sep 21 2026

    What does it mean to treat the person, not just the cancer?


    In Episode 9 of The Breast Friends Podcast, Dr. Jason Mouabbi and Dr. Paolo Tarantino are joined by Prof. Gabriella Pravettoni to explore the human side of cancer care, from psycho-oncology and quality of life to shared decision-making and the evolving role of AI.


    Topics discussed:

    • Psycho-oncology and patient-centered cancer care

    • Quality of life and individual patient priorities

    • Shared decision-making and building trust

    • The impact of family and culture on cancer care

    • AI and the changing patient-physician relationship


    🎙️ Hosted by Drs. Jason A. Mouabbi & Paolo Tarantino

    ▶️ Watch on YouTube - https://youtu.be/J88wBHM-AEY

    🎧 Listen on Spotify, Apple Podcasts, iHeartRadio, CastBox, and Amazon Music - https://linkin.bio/breastfriendspodcast


    #BreastFriends #GabriellaPravettoni #JasonMouabbi #PaoloTarantino #PsychoOncology #PatientCenteredCare #SharedDecisionMaking #QualityOfLife #BreastCancer #CommunityHealthMedia

    Show More Show Less
    44 mins
  • The Breast Friends Podcast Ep. 8 | Our Biggest Takeaways from ASCO 2026
    Aug 17 2026

    What were the most practice-changing breast cancer studies and updates presented at ASCO 2026?


    In this episode of Breast Friends, Dr. Jason Mouabbi and Dr. Paolo Tarantino share their biggest takeaways from ASCO 2026, discussing the clinical trials, FDA approvals, and emerging therapies they believe will have the greatest impact on breast cancer care.


    From HR-positive and HER2-positive disease, to triple-negative breast cancer, the conversation explores how new evidence is changing treatment decisions today—and what clinicians should be watching next.


    Topics discussed:

    • DESTINY-Breast09 and first-line HER2-positive metastatic breast cancer

    • SERENA-6 and ctDNA-guided treatment switching

    • OPTIMA and Prosigna-guided chemotherapy de-escalation

    • Giredestrant updates

    • Gedatolisib and the VIKTORIA-1 trial

    • Oral SERDs and the future of endocrine therapy

    • ADCs for metastatic triple-negative breast cancer

    • Iza-Bren and the PANKU-Breast02 trial

    • GLP-1 receptor agonists and breast cancer outcomes

    • The NHS-Galleri trial

    • Biomarkers, precision oncology, and treatment sequencing

    • Looking ahead to ESMO 2026 and SABCS


    🎙️ Hosted by Drs. Jason A. Mouabbi & Paolo Tarantino

    ▶️ Watch on YouTube - https://youtu.be/BZC5_C3KyjE

    🎧 Listen on Spotify, Apple Podcasts, iHeartRadio, CastBox and Amazon Music - https://linkin.bio/breastfriendspodcast


    The Breast Friends Podcast is part of the Community Health Media Podcast Network, where meaningful conversations help patients, caregivers, advocates, and healthcare professionals learn from one another, one story at a time.


    #BreastFriends #JasonMouabbi #PaoloTarantino #ASCO2026 #BreastCancer #MedicalOncology #HER2Positive #TripleNegativeBreastCancer #HRPositive #PrecisionOncology #CommunityHealthMedia

    Show More Show Less
    54 mins
  • The Breast Friends Podcast Ep. 7 | Dr. Daniel Hayes: The Future of Liquid Biopsy
    Jul 21 2026

    How did liquid biopsy become one of the most important tools in modern oncology?


    In Episode 7 of The Breast Friends Podcast, Dr. Jason Mouabbi and Dr. Paolo Tarantino are joined by Dr. Daniel Hayes, Past President of ASCO and one of the pioneers behind tumor markers and liquid biopsy in breast cancer.


    From the mid-1980s breakthrough clinical discovery of CA 15-3 to the cutting-edge evolution of circulating tumor cells (CTCs), ctDNA, MRD, and multi-cancer early detection (MCED), Dr. Hayes shares the captivating behind-the-scenes stories, scientific milestones, and lessons that have shaped decades of breast cancer research.


    This conversation is more than an oncology history lesson. It's a deep dive into the future of precision medicine, the reality of tumor heterogeneity, and the mystery of cancer dormancy that will define the next generation of cancer care.


    🎙️ Hosted by Drs. Jason A. Mouabbi & Paolo Tarantino

    ▶️ Watch on YouTube - https://youtu.be/PvguD4bXN-E

    🎧 Listen on Spotify, Apple Podcasts, iHeartRadio, CastBox, and Amazon Music - https://linkin.bio/breastfriendspodcast


    📺 As Mentioned in the Episode:

    Watch the historic interview featuring Dr. Daniel Hayes, Dr. Lawrence Einhorn, and John Cleland, the first patient ever cured of metastatic testicular cancer with platinum combination therapy: https://youtu.be/mKBQDSMInuI?si=YGvwlS-UfXlNvloP


    The Breast Friends Podcast is part of the Community Health Media Podcast Network, where meaningful conversations help patients, caregivers, advocates, and healthcare professionals learn from one another, one story at a time.


    #BreastCancer #Oncology #LiquidBiopsy #ctDNA #CTCs #PrecisionOncology #CancerResearch #MedicalOncology #ASCO #OncologyPodcast #MedEd

    Show More Show Less
    53 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet